ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 101 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48 | -100.0% | 10,069 | -80.1% | 0.00% | -83.3% |
| Q3 2022 | $484,000 | +22.8% | 50,536 | +3.7% | 0.01% | +50.0% |
| Q2 2022 | $394,000 | -33.7% | 48,721 | +38.7% | 0.00% | 0.0% |
| Q1 2022 | $594,000 | -19.7% | 35,126 | +2.0% | 0.00% | 0.0% |
| Q4 2021 | $740,000 | +0.3% | 34,443 | +244.5% | 0.00% | +33.3% |
| Q3 2021 | $738,000 | +609.6% | 9,998 | +427.6% | 0.00% | – |
| Q2 2021 | $104,000 | -56.7% | 1,895 | -41.8% | 0.00% | -100.0% |
| Q1 2021 | $240,000 | – | 3,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
| Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
| Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
| Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
| Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
| Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
| Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
| Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
| Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |